American Cannabis Company, Inc.
AMMJ
$0.0003
-$0.0007-70.00%
Weiss Ratings | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Fair | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 665.08 | |||
Price History | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -40.00% | |||
30-Day Total Return | -25.00% | |||
60-Day Total Return | 50.00% | |||
90-Day Total Return | 50.00% | |||
Year to Date Total Return | -25.00% | |||
1-Year Total Return | -97.41% | |||
2-Year Total Return | -98.73% | |||
3-Year Total Return | -99.41% | |||
5-Year Total Return | -99.70% | |||
52-Week High % Change | -94.12% | |||
52-Week Low % Change | 99,900.00% | |||
Price | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.02 | |||
52-Week Low Price | $0.00 | |||
52-Week Low Price (Date) | Oct 17, 2024 | |||
52-Week High Price (Date) | Mar 18, 2024 | |||
Valuation | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 185.80K | |||
Enterprise Value | 1.14M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.02 | |||
Earnings Per Share Growth | 395.74% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.12 | |||
Price/Book (Q) | -0.29 | |||
Enterprise Value/Revenue (TTM) | 0.73 | |||
Price | $0.00 | |||
Enterprise Value/EBITDA (TTM) | -0.47 | |||
Enterprise Value/EBIT | -0.43 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 185.80M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 303 974 4770 | |||
Address | 1004 Tejon Street Colorado Springs, CO 80903 | |||
Website | www.americancannabisconsulting.com | |||
Country | United States | |||
Year Founded | 2001 | |||
Profitability | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -169.63% | |||
Profit Margin | -255.48% | |||
Management Effectiveness | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -50.61% | |||
Return on Equity | -- | |||
Income Statement | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 1.57M | |||
Total Revenue (TTM) | 1.57M | |||
Revenue Per Share | $0.01 | |||
Gross Profit (TTM) | 171.70K | |||
EBITDA (TTM) | -2.41M | |||
EBIT (TTM) | -2.66M | |||
Net Income (TTM) | -4.01M | |||
Net Income Avl. to Common (TTM) | -4.01M | |||
Total Revenue Growth (Q YOY) | -49.35% | |||
Earnings Growth (Q YOY) | -5,491.53% | |||
EPS Diluted (TTM) | -0.02 | |||
EPS Diluted Growth (Q YOY) | -3,500.00% | |||
Balance Sheet | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 2.70K | |||
Cash Per Share (Q) | $0.00 | |||
Total Current Assets (Q) | 419.10K | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | -636.00K | |||
Current Ratio (Q) | 0.191 | |||
Book Value Per Share (Q) | $0.00 | |||
Total Assets (Q) | 2.12M | |||
Total Current Liabilities (Q) | 2.20M | |||
Total Debt (Q) | 960.00K | |||
Total Liabilities (Q) | 2.76M | |||
Total Common Equity (Q) | -636.00K | |||
Cash Flow | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 0.00 | |||
Cash from Financing (TTM) | -238.20K | |||
Net Change in Cash (TTM) | -90.00K | |||
Levered Free Cash Flow (TTM) | 1.22M | |||
Cash from Operations (TTM) | 148.10K | |||